Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Bacterial Community Morphogenesis Is Intimately Linked to the Intracellular Redox State
2013
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB‐oprM genes
2008
The clinical importance of emerging ESKAPE pathogens in nosocomial infections
2016
Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis
2011
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Interventions for the eradication of methicillin-resistantStaphylococcus aureus(MRSA) in people with cystic fibrosis
2013
Bacterial biofilm and associated infections
2017 Standout
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
2019 Standout
Mucoid Pseudomonas aeruginosa isolates maintain the biofilm formation capacity and the gene expression profiles during the chronic lung infection of CF patients
2011
Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis
1993
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
2008
Cystic fibrosis
2016 Standout
Management of cystic fibrosis-related diabetes in children and adolescents
2009
Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa
2009
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients
2014
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
2006
Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
2014 Standout
New insights into cystic fibrosis-related diabetes in children
2013
European Cystic Fibrosis Society Standards of Care: Quality Management in cystic fibrosis
2014
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Antibiotic resistance of bacterial biofilms
2010 Standout
Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience
2008
Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas aeruginosa Biofilms on Cystic Fibrosis Cells
2009
The golden age: gold nanoparticles for biomedicine
2011 Standout
Evaluating the “Leeds criteria” forPseudomonas aeruginosainfection in a cystic fibrosis centre
2006
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
2015
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
2014
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
What Is the Efficacy and Safety of Colistin for the Treatment of Ventilator-Associated Pneumonia? A Systematic Review and Meta-Regression
2012
A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis
2015
Why chronic wounds will not heal: a novel hypothesis
2007
Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF)
2016
Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis
2012
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Effects of ginseng onPseudomonas aeruginosamotility and biofilm formation
2011
Understanding the Intersections between Metabolism and Cancer Biology
2017 Standout
Siccanin Rediscovered as a Species-Selective Succinate Dehydrogenase Inhibitor
2009 StandoutNobel
IgG4-related disease
2014 Standout
Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders
2008
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
First Report of Lung Transplantation in a Patient With Active Pulmonary Mycobacterium simiae Infection
2012
Functional iron deficiency in adults with cystic fibrosis
1996
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Polymyxin B Identified as an Inhibitor of Alternative NADH Dehydrogenase and Malate: Quinone Oxidoreductase from the Gram-positive Bacterium Mycobacterium smegmatis
2009 StandoutNobel
Cystic fibrosis
2009
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
Folate status and the safety profile of antifolates
2002
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Microbiology of cystic fibrosis lung infections: themes and issues.
1993
Analysis of Serum IgG Subclasses in Churg-Strauss Syndrome -The Meaning of Elevated Serum Levels of IgG4
2010
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
1996 Standout
The role of bacterial biofilms in chronic infections
2013
Changes in Cystic Fibrosis Airway Microbial Community Associated with a Severe Decline in Lung Function
2015
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
2000 StandoutNature
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Updated Functional Classification of β-Lactamases
2009 Standout
Antibiotic Therapy for Chronic Infection of Pseudomonas in the Lung
1993
Bacterial Biofilm and its Role in the Pathogenesis of Disease
2020 Standout
Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis
1990
Antibiotics and Bacterial Resistance in the 21st Century
2014 Standout
In Vitro Pharmacodynamics of Levofloxacin and Other Aerosolized Antibiotics under Multiple Conditions Relevant to Chronic Pulmonary Infection in Cystic Fibrosis
2009
Update on cystic fibrosis-related diabetes
2013
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Beta-lactamase inhibitors from laboratory to clinic
1988
Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response
1990
Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger
2013 Standout
Pseudomonas Aeruginosa Biofilms in Cystic fibrosis
2010
Three Decades of β-Lactamase Inhibitors
2010 Standout
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
2015
The Effect of Sinus Surgery with Intensive follow-up on Pathogenic Sinus Bacteria in Patients with Cystic Fibrosis
2013
Management of cystic fibrosis-related diabetes in children and adolescents
2014
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Sulbactam/Ampicillin
1987
Factors Affecting Wound Healing
2010 Standout
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Activities of Pseudomonas aeruginosa Effectors Secreted by the Type III Secretion System In Vitro and during Infection
2005
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
Origins and Evolution of Antibiotic Resistance
2010 Standout
Comparison of Mycobacterial Growth Indicator Tube with Culture on RGM Selective Agar for Detection of Mycobacteria in Sputum Samples from Patients with Cystic Fibrosis
2016
General Overview on Nontuberculous Mycobacteria, Biofilms, and Human Infection
2015
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Targeted Photothermal Lysis of the Pathogenic Bacteria, Pseudomonas aeruginosa, with Gold Nanorods
2007
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
2016
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
2010
Works of T. Pressler being referenced
PHASE 3 EFFICACY AND SAFETY DATA FROM RANDOMIZED, MULTICENTER STUDY OF LIPOSOMAL AMIKACIN FOR INHALATION (ARIKACE) COMPARED WITH TOBI (R) IN CYSTIC FIBROSIS PATIENTS WITH CHRONIC INFECTION DUE TO PSEUDOMONAS AERUGINOSA
2013
Folic Acid Supplements in Vitamin Tablets: A Determinant of Hematological Drug Tolerance in Maintenance Therapy of Childhood Acute Lymphoblastic Leukemia
1986
Antibody Response to Pseudomonas aeruginosa Antigens in Cystic Fibrosis
2015
Eradication of early Pseudomonas aeruginosa infection
2005
Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response
2012
Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia
2014
Serodiagnosis ofMycobacterium abscessuscomplex infection in cystic fibrosis
2015
Understanding the natural progression in %FEV1decline in patients with cystic fibrosis: a longitudinal study
2012
Immunoglobulin allotypes and IgG subclass antibody response to Aspergillus fumigatus in cystic fibrosis patients
2004
Nontuberculous Mycobacterial Disease Is Not a Contraindication to Lung Transplantation in Patients With Cystic Fibrosis: A Retrospective Analysis in a Danish Patient Population
2012
Sultamicillin—a new antibiotic in the treatment of persistent lower respiratory tract infections caused by Haemophilus influenzae
1986
Single-dose pharmacokinetics of aerosol MP-376 (levofloxacin solution for inhalation) in cystic fibrosis patients: PK-PD implications
2008
WS1.5 First evidence of Mycobacterium abscessus biofilm in the lungs of chronically infected CF patients
2013
Cystic Fibrosis–Related Diabetes
2006